Pfizer’s CEO, Dr. Albert Bourla, in Conversation With Rabbi Angela Buchdahl

Born to Holocaust survivors and raised in the tightknit Sephardic community of Thessaloniki, Greece, Dr. Albert Bourla is wired to succeed in difficult circumstances. After working at Pfizer for nearly three decades, Dr. Bourla was appointed the CEO of Pfizer in 2019. Only a year later, he faced the biggest challenge of his career: leading the development of a COVID-19 vaccine in record speed. Refusing public funding and instead investing $2 billion at-risk, Dr. Bourla’s leadership pushed the boundaries of science and became the basis for his Bronze Medal-winning book, “Moonshot: Inside Pfizer’s Nine-Month Race to Make the Impossible Possible.” Driven to transform patients’ lives and deliver joy, Dr. Bourla’s innovative approach to medicine is grounded in purpose and courage. In 2022, Dr. Bourla was awarded the prestigious Genesis Prize, which recognizes Jewish individuals for professional achievement and contributions to humanity. An important voice in the global fight against antisemitism, he donated the $1 million prize towards the construction of the Holocaust Museum of Greece. Dr. Bourla has been an outspoken voice against antisemitism, using his platform to sound the alarm about rising hatred globally. And since the tragic events of October 7th, he has been a consistent advocate on behalf of the hostages, pressuring leaders across the world to do everything possible to fight for their release. Central Synagogue is proud to host this opportunity to hear from one of the most influential Jewish leaders of our time in conversation with Rabbi Angela Buchdahl. -- Central Synagogue is a thriving Reform Jewish congregation in New York City. Our Shabbat services are open to all and available via livestream on Fridays at 6:00 pm EST and Saturdays at 9:30 am EST. Learn more about Central Synagogue’s community, worship, and programming at www.centralsynagogue.org